ADM Tronics to Launch Medical Device for Tinnitus Sufferers on Internet; E-Commerce Marketing Approach Can Reach Millions Worldwide.

NORTHVALE, NJ--(BW HealthWire)--Dec. 9, 1998--ADM Tronics Unlimited, Inc. (NASDAQ-ADMTC) has announced that it will launch the Aurex-3, its recently FDA-cleared medical device for treatment of tinnitus, on the Internet. Tinnitus is a debilitating hearing condition commonly referred to as ringing in the ears. ADM Tronics believes this will be the first time a medical device company has opted for an on-line launch of a new medical device. This follows the recent strategic relationship signed between ADM Tronics and AllnetServices.com Corp. (OTC - AWEB) to establish a first-ever Internet portal site dedicated to therapeutic medical devices and non-invasive medical therapies. Through this e-commerce marketing and distribution system ADM Tronics expects to reach millions of people suffering from tinnitus.

"We have been researching the best way to launch the Aurex-3 in the US," commented Andre' Di Mino, COO of ADM Tronics. "The Internet gives us a vehicle to make purchasing the Aurex-3 instantly available to millions of tinnitus sufferers." The American Tinnitus Association estimates that there are 50 million people in the US with some degree of tinnitus of which, 12 million seek medical care and 1 million are incapacitated by the debilitating hearing condition.

The launch of Aurex-3 will be done on deviceline.com, the on-line portal site being jointly developed by ADM Tronics and Allnet, as previously announced. ADM Tronics and Allnet anticipate that deviceline.com will be operational in January, 1999. "The timing of this strategic relationship couldn't have been better," stated Michael Clark, Marketing Representative for ADM Tronics. "We have received many requests for the Aurex-3 and deviceline.com is a great way to get this product distributed quickly."

ADM Tronics is a technology based developer and manufacturer of a diversified line of products categorized into three distinct market segments - therapeutic, non-invasive electronic medical devices, environmentally safe chemical products and innovative topical dermatological products.